CD8A and glioma: Tumor-related antigens can be recognized by cytotoxic CD8 T cells in the context of tumors expressing MHC-I (Prins and Liau, 2003; Yang et al., 2004), suggesting that a T cell-dependent immune response might improve the outcome of glioma patients through an antigen-mediated immune response.